Premium
PLASMA GOLD ESTIMATIONS IN PATIENTS RECEIVING CHRYSOTHERAPY FOR RHEUMATOID ARTHRITIS
Author(s) -
Pole Denham J.,
Balazs Nicholas D. H.,
Maserai John
Publication year - 1971
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1971.tb92774.x
Subject(s) - rheumatoid arthritis , medicine , gold standard (test) , gold salts , antirheumatic drugs , persistence (discontinuity) , antirheumatic agents , dermatology , geotechnical engineering , engineering
Hypotheses on the mechanism of gold's antirheumatic action are reviewed, and preliminary results of estimations of plasma gold levels in five patients with rheumatoid arthritis receiving chryso‐ therapy are described. Varying levels in different patients on similar dosage, and long persistence following cessation of therapy were observed. Individual plasma gold levels are correlated with gold dermatitis.